Effectiveness of rTMS on Pain and Quality of Life in Patients With Cancer Neuropathic Pain. Clinical Trial.

Last updated: June 5, 2025
Sponsor: Fundacion Universitaria Maria Cano
Overall Status: Completed

Phase

N/A

Condition

Chronic Pain

Pain (Pediatric)

Neuropathy

Treatment

Repetitive transcranial magnetic stimulation

Clinical Study ID

NCT05480410
013008028-2021-311
  • Ages > 18
  • All Genders

Study Summary

The purpose of this study is to evaluate the effectiveness of Repetitive transcranial magnetic stimulation (rTMS) on pain and quality of life in patients with cancer neuropathic pain.

Although there are currently different therapeutic options for neuropathic pain, most are limited or restricted to pharmacotherapy. Transcranial magnetic stimulation (TMS) is a tool recently incorporated into neuroscience in the management of neuropathic cancer pain.

The study will include 10 patients with oncologic neuropathic pain who will receive 20 sessions of rTMS and the effect on pain and quality of life.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients with neuropathic pain of oncological origin

  • Patients of legal age (18 years old)

  • Patients using their cognitive faculties

Exclusion

Exclusion Criteria:

  • Pregnancy

  • History of negative reaction to TMS

  • History of seizure, history of epilepsy stroke, brain surgery and cranial metalimplants.

Study Design

Total Participants: 10
Treatment Group(s): 1
Primary Treatment: Repetitive transcranial magnetic stimulation
Phase:
Study Start date:
June 11, 2022
Estimated Completion Date:
February 23, 2023

Study Description

Neuropathic pain is defined as pain caused by a primary lesion or transient dysfunction of the central or peripheral nervous system. In cancer, it is generated as a consequence of multiple factors such as: direct compression of nerve structures, post-surgical nerve injuries, and nerve injuries secondary to chemotherapy. At least 3.5 million people around the world suffer from this symptom associated with cancer; Of this population, 38% experience pain in all stages and 80% in advanced stages, negatively impacting quality of life.

Connect with a study center

  • CORTEX

    Medellín, Antioquia 055421
    Colombia

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.